StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report sent to investors on Thursday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. PRTK has been the subject of several other research reports. HC Wainwright reiterated a neutral rating and issued a $2.15 target […]
Paratek Pharmaceuticals (NASDAQ:PRTK) Now Covered by StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com downgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a hold rating in a report issued on Saturday. Other equities research analysts have also recently issued reports about the company. HC Wainwright lowered their target price on Paratek Pharmaceuticals from $10.00 to $6.00 in a research note on Wednesday, […]
Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) had its price objective cut by HC Wainwright from $10.00 to $6.00 in a research note published on Wednesday, The Fly reports. HC Wainwright also issued estimates for Paratek Pharmaceuticals’ Q2 2023 earnings at ($0.30) EPS, Q3 2023 earnings at ($0.24) EPS, Q4 2023 earnings at ($0.19) EPS, FY2023 […]
Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. A number of other equities research analysts have also recently commented on PRTK. HC Wainwright dropped their price objective on shares of Paratek […]